The Parkinson's disease therapy developer closed the series A funding less than four months after a Eurofarma-backed seed round.
Lonza participated in the gene therapy developer's series A round alongside Partners Innovation Fund, having also licensed technology to the startup.
General Catalyst led a $51m round for the Ascension-backed healthcare automation technology developer, which has now received $119m in total.
IHH Healthcare participated in a series B round that boosted the care provider's capital base to more than $40m.
Hillhouse Capital and Chen Yi Investment are making a secondary investment in the Hualan Biological Engineering spinoff which is now valued at more than $1.9bn.
Avail Medsystems, a remote medical device startup which counts Baidu Ventures as an investor, has captured $15m in new funding.